Article
A Child with Chronic Mucocutaneous Candidiasis Harbors a Novel Gain-of-Function Mutation in STAT1.
Journal of clinical immunology - 30 Sept 2025
Xiang Yang, Sun Shuo, Wang Hong, Lo Chia-Chi, Wu Jie, Lei Wei-Te, Li Fengming, Liu Xiaodong, Dang Ningning, Ku Cheng-Lung, Guo Jing
Abstract excerpt
OBJECTIVE: Germline heterozygous gain-of-function (GOF) mutations in STAT1 impair IL-17-mediated immunity, resulting in carriers' susceptibility to chronic mucocutaneous candidiasis (CMC). JAK inhibitors have shown therapeutic effectiveness in patients with STAT1-GOF mutations. METHODS: The mutation was detected using whole-exome sequencing (WES) and confirmed by Sanger sequencing. The functional impact of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
